Tang, Chuhao
Sun, Tong
Sun, Zhengze
Duan, Hongyu
Liu, Yilin
Zhao, Lu
Li, Wenlong
Bian, Linbo
Qi, Hong
Funding for this research was provided by:
National Natural Science Foundation of China (82171022, 81974128, 82171022, 81974128, 82171022, 81974128, 82171022, 81974128, 82171022, 81974128, 82171022, 81974128, 82171022, 81974128, 82171022, 81974128, 82171022, 81974128)
The Capital Health Research and Development of Special (2020-2-4097, 2020-2-4097, 2020-2-4097, 2020-2-4097, 2020-2-4097, 2020-2-4097, 2020-2-4097, 2020-2-4097, 2020-2-4097)
Article History
Received: 1 January 2023
Accepted: 25 April 2023
First Online: 2 May 2023
Declarations
:
: The study protocol was approved by the Ethics Committee of the Peking University Third Hospital (M2020240) and adhered to the tenets of the Declaration of Helsinki. This study was registered and approved by Clinical Trials.gov on 23/06/2020 (registration number: NCT04443231). Every patient provided informed consent after receiving an adequate explanation of the study.
: Not applicable.
: The authors declare that they have no competing interests.